Results

Total Results: 1,684 records

Showing results for "prostate cancer screening".
Users also searched for: psa

  1. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2013_MaskedStats_Core.PDF
    January 01, 2013 - 3,595 0.05% 9: Sexually transmitted infections (not HIV or hepatitis) 789 0.01% 10: Immunizations and screening … 0.03% 27: Cancer of ovary 4,678 0.07% 28: Cancer of other female genital organs 1,226 0.02% 29: Cancerof prostate 13,748 0.19% 30: Cancer of testis 350 0.00% 31: Cancer of other male genital organs 199 … 0.01% 256: Medical examination/evaluation 1,188 0.02% 257: Other aftercare 4,977 0.07% 258: Other screening … Substance-related disorders 42,898 0.60% 662: Suicide and intentional self-inflicted injury 525 0.01% 663: Screening
  2. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/rt-bone-metatases-final-protocol-amendment.pdf
    August 10, 2022 - We will use DistillerSR® to improve efficiency in screening articles and risk of bias assessment. … Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases
  3. effectivehealthcare-admin.ahrq.gov/sites/default/files/product/pdf/rt-bone-metatases-final-protocol-amendment.pdf
    August 10, 2022 - We will use DistillerSR® to improve efficiency in screening articles and risk of bias assessment. … Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases
  4. effectivehealthcare.ahrq.gov/sites/default/files/renal-cancer_executive.pdf
    February 01, 2016 - aquaporin 1 and perilipin 2 differentiate renal carcinomas from other imaged renal masses and bladder and prostatecancer.: Initial experience using 99mTc-MIBI SPECT/CT for the differentiation of oncocytoma from renal
  5. effectivehealthcare-admin.ahrq.gov/sites/default/files/renal-cancer_executive.pdf
    February 01, 2016 - aquaporin 1 and perilipin 2 differentiate renal carcinomas from other imaged renal masses and bladder and prostatecancer.: Initial experience using 99mTc-MIBI SPECT/CT for the differentiation of oncocytoma from renal
  6. ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/education/curriculum-tools/shareddecisionmaking/webinars/sharewebinar518-slides.pdf
    May 18, 2015 - Prenatal screening for Down syndrome: a survey of willingness in women and family physicians to engage … Decision aids for people facing health treatment or screening decisions. … Consequences of not respecting patient preferences for cancer screening: opportunity lost. …  If each provider in an organization has a PSA screening rate of 100% or 0%, the organization is … Decision aids for people facing health treatment or screening decisions.
  7. www.ahrq.gov/sites/default/files/wysiwyg/professionals/education/curriculum-tools/shareddecisionmaking/webinars/sharewebinar518-slides.pdf
    May 18, 2015 - Prenatal screening for Down syndrome: a survey of willingness in women and family physicians to engage … Decision aids for people facing health treatment or screening decisions. … Consequences of not respecting patient preferences for cancer screening: opportunity lost. …  If each provider in an organization has a PSA screening rate of 100% or 0%, the organization is … Decision aids for people facing health treatment or screening decisions.
  8. www.ahrq.gov/health-literacy/improve/pharmacy/guide/train2.html
    September 01, 2020 - actually place greater burdens on patients, such as in the process of informed decision-making for prostatecancer screening.
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-muscle-invasive_executive.pdf
    June 01, 2015 - 1 Comparative Effectiveness Review Number 152 Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer Executive Summary Background Nature and Burden of Nonmetastatic Muscle-Invasive Bladder Cancer Bladder cancer is the 4th most commonly diagnosed cancer in men and the 10th most commonly diagnosed cancer i…
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/bladder-cancer-muscle-invasive_executive.pdf
    June 01, 2015 - 1 Comparative Effectiveness Review Number 152 Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer Executive Summary Background Nature and Burden of Nonmetastatic Muscle-Invasive Bladder Cancer Bladder cancer is the 4th most commonly diagnosed cancer in men and the 10th most commonly diagnosed cancer i…
  11. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2014_MaskedStats_Core.PDF
    January 01, 2014 - 3,334 0.05% 9: Sexually transmitted infections (not HIV or hepatitis) 740 0.01% 10: Immunizations and screening … 0.03% 27: Cancer of ovary 4,582 0.06% 28: Cancer of other female genital organs 1,168 0.02% 29: Cancerof prostate 13,018 0.18% 30: Cancer of testis 335 0.00% 31: Cancer of other male genital organs 187 … 0.01% 256: Medical examination/evaluation 1,036 0.01% 257: Other aftercare 4,544 0.06% 258: Other screening … Substance-related disorders 43,410 0.61% 662: Suicide and intentional self-inflicted injury 533 0.01% 663: Screening
  12. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2014_MaskedStats_Core_Weighted.PDF
    January 01, 2014 - 0.05% 9: Sexually transmitted infections (not HIV or hepatitis) 3,700 0.01% 10: Immunizations and screening … DXCCS1 DXCCS1 Frequency Percent of Total 28: Cancer of other female genital organs 5,840 0.02% 29: Cancerof prostate 65,090 0.18% 30: Cancer of testis 1,675 0.00% 31: Cancer of other male genital organs … 0.01% 256: Medical examination/evaluation 5,180 0.01% 257: Other aftercare 22,720 0.06% 258: Other screening … Substance-related disorders 217,050 0.61% 662: Suicide and intentional self-inflicted injury 2,665 0.01% 663: Screening
  13. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2014_MaskedStats_Core.PDF
    January 01, 2014 - 0.05% 9: Sexually transmitted infections (not HIV or hepatitis) 1,757 0.01% 10: Immunizations and screening … 0.04% 27: Cancer of ovary 10,937 0.07% 28: Cancer of other female genital organs 2,648 0.02% 29: Cancerof prostate 31,180 0.21% 30: Cancer of testis 749 0.01% 31: Cancer of other male genital organs 426 … 0.01% 256: Medical examination/evaluation 1,596 0.01% 257: Other aftercare 6,821 0.05% 258: Other screening … Substance-related disorders 101,995 0.68% 662: Suicide and intentional self-inflicted injury 959 0.01% 663: Screening
  14. psnet.ahrq.gov/perspective/safety-radiology
    October 01, 2013 - Medicolegal and ethical issues in radiologic screening. Semin Roentgenol. 2003;38:77-86. … While physicians may understand that, for example, finding and treating a small prostate cancer in an
  15. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2008_MaskedStats_Core_Weighted.PDF
    January 01, 2008 - 0.05% 9: Sexually transmitted infections (not HIV or hepatitis) 4,624 0.01% 10: Immunizations and screening … 0.05% 27: Cancer of ovary 27,026 0.07% 28: Cancer of other female genital organs 7,294 0.02% 29: Cancerof prostate 107,985 0.27% 30: Cancer of testis 2,221 0.01% 31: Cancer of other male genital organs … 0.01% 256: Medical examination/evaluation 12,394 0.03% 257: Other aftercare 34,850 0.09% 258: Other screening … Substance-related disorders 230,073 0.58% 662: Suicide and intentional self-inflicted injury 521 0.00% 663: Screening
  16. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2012_MaskedStats_Core.PDF
    January 01, 2012 - 3,421 0.05% 9: Sexually transmitted infections (not HIV or hepatitis) 755 0.01% 10: Immunizations and screening … 0.04% 27: Cancer of ovary 4,699 0.06% 28: Cancer of other female genital organs 1,285 0.02% 29: Cancerof prostate 14,676 0.20% 30: Cancer of testis 386 0.01% 31: Cancer of other male genital organs 178 … 0.01% 256: Medical examination/evaluation 1,337 0.02% 257: Other aftercare 5,293 0.07% 258: Other screening … Substance-related disorders 44,878 0.62% 662: Suicide and intentional self-inflicted injury 457 0.01% 663: Screening
  17. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2011_MaskedStats_Core_Weighted.PDF
    January 01, 2011 - 0.05% 9: Sexually transmitted infections (not HIV or hepatitis) 3,896 0.01% 10: Immunizations and screening … 0.04% 27: Cancer of ovary 24,257 0.06% 28: Cancer of other female genital organs 6,234 0.02% 29: Cancerof prostate 99,596 0.26% 30: Cancer of testis 1,920 0.00% 31: Cancer of other male genital organs … 0.01% 256: Medical examination/evaluation 8,405 0.02% 257: Other aftercare 29,401 0.08% 258: Other screening … Substance-related disorders 238,933 0.62% 662: Suicide and intentional self-inflicted injury 2,048 0.01% 663: Screening
  18. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2009_MaskedStats_Core.PDF
    January 01, 2009 - 4,022 0.05% 9: Sexually transmitted infections (not HIV or hepatitis) 879 0.01% 10: Immunizations and screening … DXCCS1 DXCCS1 Frequency Percent of Total 28: Cancer of other female genital organs 1,369 0.02% 29: Cancerof prostate 19,418 0.25% 30: Cancer of testis 380 0.00% 31: Cancer of other male genital organs 171 … 0.01% 256: Medical examination/evaluation 1,116 0.01% 257: Other aftercare 7,135 0.09% 258: Other screening … Substance-related disorders 46,739 0.60% 662: Suicide and intentional self-inflicted injury 407 0.01% 663: Screening
  19. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2010_MaskedStats_Core.PDF
    January 01, 2010 - 4,134 0.05% 9: Sexually transmitted infections (not HIV or hepatitis) 775 0.01% 10: Immunizations and screening … 0.05% 27: Cancer of ovary 5,425 0.07% 28: Cancer of other female genital organs 1,375 0.02% 29: Cancerof prostate 17,659 0.23% 30: Cancer of testis 517 0.01% 31: Cancer of other male genital organs 212 … 0.01% 256: Medical examination/evaluation 2,569 0.03% 257: Other aftercare 6,375 0.08% 258: Other screening … Substance-related disorders 49,903 0.64% 662: Suicide and intentional self-inflicted injury 537 0.01% 663: Screening
  20. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2010_MaskedStats_Core_Weighted.PDF
    January 01, 2010 - 0.05% 9: Sexually transmitted infections (not HIV or hepatitis) 3,957 0.01% 10: Immunizations and screening … 0.05% 27: Cancer of ovary 27,447 0.07% 28: Cancer of other female genital organs 6,982 0.02% 29: Cancerof prostate 88,400 0.23% 30: Cancer of testis 2,653 0.01% 31: Cancer of other male genital organs … 0.01% 256: Medical examination/evaluation 13,285 0.03% 257: Other aftercare 31,464 0.08% 258: Other screening … Substance-related disorders 250,901 0.64% 662: Suicide and intentional self-inflicted injury 2,720 0.01% 663: Screening